🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07777744
Recruiting Observational

Severe Complications During Ventricular Tachycardia or Premature Ventricular Complex Ablation

NCT07777744 · tracked via the Priya Life Science China tracker
Sponsor
University Hospital, Basel, Switzerland
Phase
Observational
Started
2024-07-01
Last updated
2026-08-20

Condition(s) studied

Ventricular Tachycardia (VT)Premature Ventricular Complexes

Study summary

The investigators aim to characterize patients presenting with a severe ventricular tachycardia (VT) and premature ventricular complex (PVC)-ablation-related complication including patient characteristics, procedural details and subsequent management of the complication by gathering existing patient-level data.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: * Centers : Centers participating in the present collaborative study group. Invitation to participate will be based either upon personal referral of one of the investigator, previous collaboration or based on a meta-analytic review of the literature published on the subject within the past 20 years. * Patients: Females and males of \>18 years undergoing any type of VT/PVC ablation. While we will accept redo-procedure we will ask for a unique patient-identifier to link procedures belonging to the same patients together. * Interventions: VT/PVC ablation (first intervention or re-do) as routinely performed by the participating centers * Outcomes: Severe complications, defined as hemodynamic instability requiring mechanical intensive-care management, tamponade, stroke, cardiac arrest, myocardial infarction, phrenic nerve palsies, major bleeding requiring transfusion, vascular or cardiac complication requiring surgery, procedure-related death. * Setting: Observational cohort studies, registries, retrospective cohort studies. Data stemming from RCTs (Randomized controlled trials) will not be collected as they likely do not represent a "real-life" setting. * Length of follow-up: Peri-procedural complications * Years considered: Not limited to a specific time-frame, but to reflect common ablation practices, we will focus on data from the 20 past years. * Number of patients provided : No lower limit of patients provided per dataset or ablation volume per year to include high- as well as low-volume centers Exclusion Criteria: * Refusal of the center to participate. * Less than 10 procedures available in the dataset (no case reports) * Missing essential baseline characteristics, missing collection of sufficient details regarding each complication.

Primary outcome measure(s)

Trial sites (25)

FacilityCityRegionStatus
Rush University Medical Center Chicago Illinois Recruiting
University of Michigan Michigan Center Michigan Recruiting
Medical University of Graz Graz Austria Recruiting
Université Laval Québec Canada Recruiting
The First Affiliated Hospital of Nanjing Medical University Nanjing China Recruiting
University Hospital Center Sestre milosrdnice Zagreb Croatia Recruiting
CHU Bordeaux Bordeaux France Recruiting
Centre Hospitalier Universitaire Trousseau Chambray-lès-Tours France Recruiting
University Hospital Poitier Poitiers France Recruiting
Clinique Pasteur Toulouse Toulouse France Recruiting
Zentralklinik Bad Bercka Bad Berka Germany Recruiting
Uniklinik Freiburg Bad Krozingen Germany Recruiting
Carl-Thiem-Klinikum Cottbus Germany Recruiting
Universitätsklinikum Münster Münster Germany Recruiting
University of Patras Pátrai Greece Recruiting
Sheba Medical Center Ramat Gan Israel Recruiting
Citta della Salute e della Scienza di Torino Torino Italy Recruiting
Mount Elisabeth Medical Centre Singapore Singapore Recruiting
University Medical Center Ljubljana Ljubljana Slovenia Recruiting
Hospital Universitario Ramón y Cajal Madrid Spain Recruiting
University Hospital Basel Basel Switzerland Recruiting
Inselspital Bern Bern Switzerland Recruiting
Ankara City Hospital Ankara Turkey (Türkiye) Recruiting
Hacettepe University Ankara Turkey (Türkiye) Recruiting
Royal Papworth Hospital Cambridge United Kingdom Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07777744 on ClinicalTrials.gov ↗ ← All trials in China